These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Early combined treatment with cilostazol and bone marrow-derived endothelial progenitor cells markedly attenuates pulmonary arterial hypertension in rats. Sun CK, Lee FY, Sheu JJ, Yuen CM, Chua S, Chung SY, Chai HT, Chen YT, Kao YH, Chang LT, Yip HK. J Pharmacol Exp Ther; 2009 Sep 04; 330(3):718-26. PubMed ID: 19528354 [Abstract] [Full Text] [Related]
10. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Sahara M, Sata M, Morita T, Nakamura K, Hirata Y, Nagai R. Circulation; 2007 Jan 30; 115(4):509-17. PubMed ID: 17242277 [Abstract] [Full Text] [Related]
16. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling. Yen CH, Leu S, Lin YC, Kao YH, Chang LT, Chua S, Fu M, Wu CJ, Sun CK, Yip HK. J Cardiovasc Pharmacol; 2010 Jun 27; 55(6):574-84. PubMed ID: 20224427 [Abstract] [Full Text] [Related]
18. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension. Xia L, Fu GS, Yang JX, Zhang FR, Wang XX. Cytotherapy; 2009 Jun 27; 11(4):492-502. PubMed ID: 19526390 [Abstract] [Full Text] [Related]
20. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. Spees JL, Whitney MJ, Sullivan DE, Lasky JA, Laboy M, Ylostalo J, Prockop DJ. FASEB J; 2008 Apr 27; 22(4):1226-36. PubMed ID: 18032636 [Abstract] [Full Text] [Related] Page: [Next] [New Search]